Compare Fabrinet (FN) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance

Fabrinet (FN) trades at $474.19, down 1.78% on the day, with a bearish technical signal despite strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.72 exceeding expectations. Analyst consensus remains strongly bullish with a $733 price target, though technical indicators show selling pressure with support at $473 and resistance at $484.

FN presents a compelling growth story driven by AI infrastructure demand, with revenue projected to grow from $3.42B to $4.2B in 2026. However, premium valuation metrics (P/E 41.81, P/B 7.57) and technical bearishness create near-term headwinds. The risk-reward favors long-term investors given the company's strategic positioning in optical communications and debt-free balance sheet.

Marsh (MRSH) trades at $178.05, down 1.92% on the day, near the analyst consensus low target of $175. The stock shows bullish technical signals with strong moving average support, while recent quarterly earnings have consistently beaten expectations. The company maintains solid profitability with a 14.26% net margin and 27.42% ROE, supported by a 10% dividend increase announced in July 2026. Revenue growth has been steady, reaching $26.98B in 2025, though profit margins show slight compression from previous years.

The outlook remains balanced with strong fundamentals and shareholder returns offset by valuation concerns and rising cost pressures. Investment opportunity centers on consistent earnings beats, dividend growth, and AI initiatives through Oliver Wyman. Key risks include premium valuation multiples, softer insurance pricing tailwinds, and execution challenges in sustaining organic growth as operating expenses rise.